ADMA Biologics Inc
ADMA
Common Stock
$4.93
Sector: Health Care
Industry: Biotechnology
Sub-Industry: Biotechnology
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.51 | -$0.88 | -$0.89 | -$1.45 | -$1.91 |
Sales/Revenue | $80.94 M | $42.22 M | $29.35 M | $16.99 M | $22.76 M |
Sales Growth | 91.72% | 43.85% | 72.79% | -25.37% | 0.00% |
Gross Margin | +0.57 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$71.65 M | -$75.75 M | -$48.28 M | -$65.74 M | -$43.76 M |
Net Income Growth | 5.41% | -56.90% | 26.56% | -50.24% | 0.00% |
Net Margin | -88.52 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$53.12 M | -$60.97 M | -$38.17 M | -$52.94 M | -$31.57 M |
Cost of Goods Sold (incl D&A) | $80.48 M | $62.01 M | $40.35 M | $43.04 M | $36.90 M |
Cost of Goods Sold (excl D&A) | $74.99 M | $58.06 M | $37.09 M | $39.59 M | $34.21 M |
Cost of Goods Growth | 29.80% | 53.68% | -6.25% | 16.63% | 0.00% |
Research & Development | $3.89 M | $5.91 M | $2.34 M | $3.93 M | $6.23 M |
Other SG&A Expenses | $0.00 M | $39.22 M | $28.08 M | $26.41 M | $13.89 M |
Interest Expense | $13.06 M | $11.99 M | $8.99 M | $5.52 M | $3.29 M |
Income Tax | -$0.24 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.13 | -$0.09 | -$0.13 | -$0.15 |
Sales/Revenue | $29.10 M | $26.38 M | $20.68 M | $17.83 M |
Sales Growth | 10.31% | 27.57% | 15.98% | 11.10% |
Gross Margin | +0.57 | 0.00 | 0.00 | 0.00 |
Net Income | -$25.01 M | -$16.65 M | -$17.71 M | -$18.91 M |
Net Income Growth | -50.20% | 6.00% | 6.31% | -2.86% |
Net Margin | -88.52 | 0.00 | 0.00 | 0.00 |
EBITDA | -$13.22 M | -$11.67 M | -$13.01 M | -$14.26 M |
Cost of Goods Sold (incl D&A) | $25.62 M | $23.05 M | $20.47 M | $19.01 M |
Cost of Goods Sold (excl D&A) | $24.03 M | $21.53 M | $19.05 M | $17.69 M |
Cost of Goods Growth | 11.15% | 12.58% | 7.69% | 5.92% |
Research & Development | $0.62 M | $0.73 M | $0.77 M | $1.16 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $13.87 M | $13.24 M |
Interest Expense | $3.39 M | $3.32 M | $3.30 M | $3.25 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $58.20 M | $45.85 M | $33.14 M | $30.12 M | $30.47 M |
Cash and Short-Term Investment | $51.09 M | $55.92 M | $26.75 M | $22.75 M | $44.61 M |
Cash and Short-Term Investment Growth | -8.64% | 109.03% | 17.57% | -48.99% | 0.00% |
Long Term Debt | $102.33 M | $97.30 M | $84.50 M | $44.19 M | $42.97 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $276.25 M | $207.67 M | $127.09 M | $88.88 M | $108.02 M |
Total Assets Growth | 33.02% | 63.41% | 43.00% | -17.72% | 0.00% |
Inventories | $124.72 M | $81.54 M | $53.06 M | $18.62 M | $12.63 M |
Finished Goods | $29.00 M | $19.20 M | $5.23 M | $4.60 M | $0.97 M |
Short Term Debt | $0.59 M | $0.37 M | $0.23 M | $0.03 M | $0.00 M |
Total Liabilities | $135.08 M | $119.42 M | $100.90 M | $69.11 M | $67.69 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $60.33 M | $58.20 M | $55.08 M | $53.32 M | $50.37 M |
Cash and Short-Term Investment | $69.50 M | $51.09 M | $34.41 M | $42.41 M | $61.97 M |
Cash and Short-Term Investment Growth | 36.05% | 48.47% | -18.86% | -31.56% | 0.00% |
Long Term Debt | $145.71 M | $102.33 M | $101.28 M | $100.95 M | $99.83 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $308.03 M | $276.25 M | $238.64 M | $232.81 M | $235.67 M |
Total Assets Growth | 11.50% | 15.76% | 2.50% | -1.21% | 0.00% |
Inventories | $139.15 M | $124.72 M | $114.12 M | $99.70 M | $94.15 M |
Finished Goods | $47.97 M | $29.00 M | $18.93 M | $17.48 M | $21.17 M |
Short Term Debt | $0.65 M | $0.59 M | $0.50 M | $0.39 M | $0.32 M |
Total Liabilities | $181.10 M | $135.08 M | $135.86 M | $121.22 M | $123.16 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2024-08-16 | 72.86 | $140.10 K |
Quarter | Amount | Yield |
---|
|
|